Patient Achieves Remission With CAR-T Cell Therapy for Aggressive Brain Tumors

managedcaremag.com December 30, 2016

A case study published in the December 29 issue of the New England Journal of Medicine outlines the results of a patient treated with his own genetically modified CAR-T cells, using central memory T cells, a stem-cell-like subset of immune cells. In CAR-T therapy, T cells are engineered by adding chimeric antigen receptors (CARs), which help the immune cells target tumors.